# Outcomes-based agreement
> An outcomes-based agreement links a drug’s reimbursement to the real-world results it delivers in a patient population.
Source: https://www.visfo.health/glossary/outcomes-based-agreement
Updated: 2026-06-16T15:10:40.108914+00:00

What is an outcomes-based agreement?
An outcomes-based agreement is a contract between a pharmaceutical company and a payer in which reimbursement or pricing is tied to the clinical or economic outcomes achieved. If the agreed-upon outcomes are not met, the manufacturer may be required to provide a rebate, refund, or other adjustment.
Why are outcomes-based agreements important in market access?
They help align pricing with value and reduce payer risk. These agreements support earlier access, foster trust between manufacturers and payers, and encourage real-world data collection. They are especially relevant for high-cost or innovative therapies where long-term impact may not be fully known at launch.